New screening tools aim to catch breast cancer earlier in high-risk women
NCT ID NCT00006421
First seen Oct 31, 2025 · Last updated Jun 16, 2026 · Updated 37 times
Summary
This study looked at 200 women aged 25-55 who have a high genetic risk of breast cancer due to BRCA1 or BRCA2 gene mutations. Researchers tested new screening methods like breast MRI and duct lavage alongside standard mammograms to see if they could detect cancer earlier. The goal was to compare breast tissue differences between mutation carriers and non-carriers and improve early detection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.